Condition
Low Molecular Weight Heparin
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
P 3 (3)
Trial Status
Completed2
Terminated1
Not Yet Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06991530CompletedPrimary
Effect of Low Molecular Weight Heparin in Freeze-thaw Embryo Transfer Cycles in Women With Recurrent Implantation Failure
NCT06494878Phase 3Not Yet Recruiting
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
NCT02935530Phase 3Completed
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
NCT02991950Phase 3Terminated
Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial
Showing all 4 trials